The Cooper Companies, Inc.
COO
Κατάταξη σε μετοχές
#1930
The Cooper Companies, Inc. (COO) operates as a global medical device firm,... The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
Τιμή μετοχής
$57.90
Κεφαλαιοποίηση
$11.01B
Αλλαγή (1 ημέρα)
-0.07%
Αλλαγή (1 έτος)
-19.55%
Χώρα
US
Εμπόριο The Cooper Companies, Inc. (COO)
Κατηγορία
Healthcare
EPS για The Cooper Companies, Inc. (COO)
EPS στις July 2026 TTM: $2.93
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή της μετοχής της The Cooper Companies, Inc., το τρέχον EPS της εταιρείας (TTM) είναι $2.93. Στο τέλος του 2024, η εταιρεία είχε EPS $1.97, αύξηση σε σχέση με το EPS του 2023 που ήταν $1.49.
Ιστορικό EPS της The Cooper Companies, Inc. από 2000 έως 2026
EPS στο τέλος κάθε έτους
| Έτος | EPS | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $2.93 | 55.85% |
| 2025 | $1.88 | -4.57% |
| 2024 | $1.97 | 32.21% |
| 2023 | $1.49 | -23.98% |
| 2022 | $1.96 | -96.72% |
| 2021 | $59.73 | 1,129.01% |
| 2020 | $4.86 | -48.68% |
| 2019 | $9.47 | 232.28% |
| 2018 | $2.85 | -62.65% |
| 2017 | $7.63 | 35.04% |
| 2016 | $5.65 | 34.52% |
| 2015 | $4.20 | -25.13% |
| 2014 | $5.61 | -7.88% |
| 2013 | $6.09 | 17.57% |
| 2012 | $5.18 | 38.50% |
| 2011 | $3.74 | 50.81% |
| 2010 | $2.48 | 11.21% |
| 2009 | $2.23 | 52.74% |
| 2008 | $1.46 | -684.00% |
| 2007 | $-0.25 | -116.78% |
| 2006 | $1.49 | -27.67% |
| 2005 | $2.06 | -27.21% |
| 2004 | $2.83 | 28.64% |
| 2003 | $2.20 | 37.50% |
| 2002 | $1.60 | 28.00% |
| 2001 | $1.25 | 22.55% |
| 2000 | $1.02 | 0.00% |
EPS για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | EPS | Διαφορά EPS | Χώρα |
|---|---|---|---|
| $8.85 | 202.05% |
US
|
|
| $6.41 | 118.61% |
FR
|
|
| - | - |
JP
|
|
| $3.32 | 13.31% |
US
|
|
| - | - |
CH
|
